Comparison

Regorafenib monohydrate European Partner

€34.00
Excl. VAT
Item no. TMO-T1792L-5mg
Manufacturer TargetMol
CASRN 1019206-88-2
Amount 5mg
Category
Type Inhibitors
Specific against other
Purity 99.47%
Citations Zopf D, et al. Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models. Cancer Med. 2016 Nov;5(11):3176-3185.
Smiles O.CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 1019206-88-2
Available
Short Description
Regorafenib Monohydrate is a novel oral multikinase inhibitor with IC50 values of 13, 4.2, 46, 22, 7, 1.5, 2.5, 28, 19 nM for VEGFR1, murine VEGFR2, murine VEGFR3, PDGFR-β, KIT, RET, RAF-1, B-RAF and B-RAF(V600E) respectively.
Shipping
cool pack
Storage
-20°
Molecular Weight
500, 83
Pathway
Autophagy|||Angiogenesis|||Tyrosine Kinase/Adaptors|||Apoptosis|||MAPK
Target
VEGFR|||c-RET|||Autophagy|||Raf|||PDGFR|||c-Kit

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
Listprice: €34.00
Price: €34.00
available

Delivery expected until 9/4/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close